BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21925424)

  • 1. Re: A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.
    Woo EJ
    Spine J; 2011 Aug; 11(8):804; author reply 804-5. PubMed ID: 21925424
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned".
    Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
    Spine J; 2011 Nov; 11(11):1082-3; author reply 1083-6. PubMed ID: 22078853
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the editor regarding "A critical review of recombinant human morphogenetic protein-2 trials in spine surgery: emerging safety concerns and lessons learned".
    Anderson PA
    Spine J; 2012 Apr; 12(4):356; author reply 356-7; discussion 357-9. PubMed ID: 22464143
    [No Abstract]   [Full Text] [Related]  

  • 4. Folly of FDA-approval studies for bone morphogenetic protein.
    Mirza SK
    Spine J; 2011 Jun; 11(6):495-9. PubMed ID: 21729798
    [No Abstract]   [Full Text] [Related]  

  • 5. Resetting standards for sponsored research: do conflicts influence results?
    Spengler DM
    Spine J; 2011 Jun; 11(6):492-4. PubMed ID: 21729797
    [No Abstract]   [Full Text] [Related]  

  • 6. A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors.
    Carragee EJ; Ghanayem AJ; Weiner BK; Rothman DJ; Bono CM
    Spine J; 2011 Jun; 11(6):463-8. PubMed ID: 21729794
    [No Abstract]   [Full Text] [Related]  

  • 7. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.
    Carragee EJ; Hurwitz EL; Weiner BK
    Spine J; 2011 Jun; 11(6):471-91. PubMed ID: 21729796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acknowledging the elephant in the room: conflict of interest in industry-sponsored clinical research.
    Hart RA
    Spine J; 2011 Aug; 11(8):703-4. PubMed ID: 21925414
    [No Abstract]   [Full Text] [Related]  

  • 9. Exposing conflicts of interest and complications of rhBMP-2.
    Chi JH
    Neurosurgery; 2011 Oct; 69(4):N21-2. PubMed ID: 21900807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Too good to be true].
    Brox JI
    Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2228-9. PubMed ID: 22085945
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information?
    Resnick D; Bozic KJ
    Ann Intern Med; 2013 Jun; 158(12):912-3. PubMed ID: 23778909
    [No Abstract]   [Full Text] [Related]  

  • 12. Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research.
    Laine C; Guallar E; Mulrow C; Taichman DB; Cornell JE; Cotton D; Griswold ME; Localio AR; Meibohm AR; Stack CB; Williams SV; Goodman SN
    Ann Intern Med; 2013 Jun; 158(12):916-8. PubMed ID: 23778911
    [No Abstract]   [Full Text] [Related]  

  • 13. Medtronic submits full data on spinal protein to independent scrutiny.
    Cohen D
    BMJ; 2011 Aug; 343():d5484. PubMed ID: 21878463
    [No Abstract]   [Full Text] [Related]  

  • 14. First reviews are published that are based on the "totality of the evidence".
    Kmietowicz Z
    BMJ; 2013 Jun; 346():f3909. PubMed ID: 23775921
    [No Abstract]   [Full Text] [Related]  

  • 15. A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research.
    Carragee EJ; Baker RM; Benzel EC; Bigos SJ; Cheng I; Corbin TP; Deyo RA; Hurwitz EL; Jarvik JG; Kang JD; Lurie JD; Mroz TE; Oner FC; Peul WC; Rainville J; Ratliff JK; Rihn JA; Rothman DJ; Schoene ML; Spengler DM; Weiner BK
    Spine J; 2012 Oct; 12(10):877-80. PubMed ID: 23199819
    [No Abstract]   [Full Text] [Related]  

  • 16. The changing structure of industry-sponsored clinical research: pioneering data sharing and transparency.
    Kuntz RE
    Ann Intern Med; 2013 Jun; 158(12):914-5. PubMed ID: 23778910
    [No Abstract]   [Full Text] [Related]  

  • 17. Important considerations on bone morphogenetic protein-2 and neuroinflammation.
    Heggeness MH
    Spine J; 2011 Jun; 11(6):506. PubMed ID: 21729800
    [No Abstract]   [Full Text] [Related]  

  • 18. Another complication associated with rhBMP-2?
    Kang JD
    Spine J; 2011 Jun; 11(6):517-9. PubMed ID: 21612984
    [No Abstract]   [Full Text] [Related]  

  • 19. An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions.
    Smoljanovic T; Bojanic I
    Spine J; 2011 Jun; 11(6):520-1. PubMed ID: 21612986
    [No Abstract]   [Full Text] [Related]  

  • 20. A historic moment for open science: the Yale University Open Data Access project and medtronic.
    Krumholz HM; Ross JS; Gross CP; Emanuel EJ; Hodshon B; Ritchie JD; Low JB; Lehman R
    Ann Intern Med; 2013 Jun; 158(12):910-1. PubMed ID: 23778908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.